Medical Device Startup Inito selected for Y Combinator Winter 19 Cohort
Bangalore based medical technology startup, Inito, has been selected by Y Combinator in its Winter 2019 Cohort. The startup has produced a small device that enables smartphones to perform lab-grade fertility diagnostic tests at home. Inito has previously raised US$1.8 Million from angel investors in India and Singapore.
“Inito aims to put a diagnostic lab in every home and personalize medical diagnosis for every human. Being funded by Y Combinator allows us to think globally and access global expertise and resources which will enable our mission,” said Aayush Rai, Co-Founder, Inito.
Inito is the first Indian medical device startup to be supported by Y Combinator. The Silicon Valley based startup incubator has invested in nearly 30 Indian startups.
Inito’s device is based on the company’s patent-pending ‘Flat-lens’ technology and comes with the Inito Reader, App and test strips. Right now, Inito’s Monitor measures two fertility hormones, Estrogen & Luteinizing Hormone (LH), in urine and enables women to track their fertile days at home and increase the chances of getting pregnant by 89%. It’s AI based app understands cycle variations for every individual user and gives highly accurate results unique to every woman’s body.
Inito now plans to add 8 more hormone tests to the device. This will allow the app to predict several key metrics of fertility for users and diagnose fertility conditions without going to the lab. By doing so, the company aims to disrupt the US$30 billion fertility market.
“The data set of hormones collected through 50,000 plus tests taken on the device till now is arguably the largest cloud based dataset of fertility hormones in the world. Using big data analytics and artificial intelligence, Inito will be able to make more accurate predictions about fertility for its future users,” read a communiqué from the company.
The company was started by IIT Roorkee alumnus, Aayush Rai and IIT Madras alum, Varun AV in 2015.
